Sheba Medical Center
| Israel | Turkey | Austria | |
| NanoKnife | from $18,500 | from $9,500 | from $25,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $42,000 | from $22,500 | from $40,000 |
| Gastric polyps removal | from $2,200 | from $990 | from $5,000 |
| Da Vinci Robotic System | from $22,500 | from $9,500 | from $22,000 |
| CyberKnife | from $17,500 | from $4,750 | from $50,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Colon cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Colon cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Colon cancer treatment journey.
Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.
Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.
Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.
Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.